The American Cancer Society estimates that this year in the United States, there will be 268,490 new cases of prostate cancer. It also estimates that 34,500 men will die from the cancer in 2022. Other than skin cancer, prostate cancer is the most common cancer in American men. These stark statistics are why the California … Continue reading CIRM Grants $5.8M for Prostate Cancer Immunotherapy Research
prostate cancer
A New Model for Diversity in Scientific and Medical Research
Nature Cell Biology cover The global pandemic exposed deep inequities in our health care system and highlighted the need for more diversity in scientific and medical research. The virus hit communities of color the hardest. That in part prompted widespread calls for greater diversity at every level of research. New models for research A recently … Continue reading A New Model for Diversity in Scientific and Medical Research
Predicting the Impact of Stem Cell Cures on Healthcare Burden in California
A new independent report says developing stem cell treatments and cures for some of the most common and deadly diseases could produce multi-billion dollar benefits for California in reduced healthcare costs and improved quality and quantity of life. The report, by researchers at the University of Southern California’s Leonard D. Schaeffer Center for Health Policy … Continue reading Predicting the Impact of Stem Cell Cures on Healthcare Burden in California
Prostate Cancer Research Gets Support from CIRM
A program hoping to supercharge prostate cancer research by using a patient’s own immune system cells received $3.99 million from the California Institute for Regenerative Medicine (CIRM) A leading cause of death Prostate cancer is the second‑leading cause of cancer deaths in U.S. men. Each year, about 170,000 men are diagnosed, and more than 29,000 … Continue reading Prostate Cancer Research Gets Support from CIRM
New developments in prostate cancer from UCLA
Today we’re bringing you a research update from a CIRM-funded team at UCLA that’s dedicated to finding a cure for prostate cancer. The team is led by Dr. Owen Witte, the director of the UCLA Broad Stem Cell Research Center and a Howard Hughes Investigator. Dr. Witte is well known for his work in leukemia … Continue reading New developments in prostate cancer from UCLA
UCLA scientists find new targets for late-stage prostate cancer
Prostate cancer, which currently affects 3 million men in the United States, is no longer a death sentence if caught early. The five-year survival rate is very high (~98%) because of effective treatments like hormone therapy, chemotherapy, surgery, and radiation—and for many men with slow-progressing tumors, the wait-and-watch approach offers an alternative to treatment. However, … Continue reading UCLA scientists find new targets for late-stage prostate cancer
Stem cells and prostate cancer are more similar than we thought
Prostate cancer is a scary word for men, no matter how macho or healthy they are. These days however, prostate cancer is no longer a death sentence for them. In fact, many men survive this disease if diagnosed early. However, for those unlucky ones who have more advanced stages of prostate cancer (where the tumor … Continue reading Stem cells and prostate cancer are more similar than we thought